During the past decade, Essendon Eye Clinic conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Essendon Eye Clinic" are "Geographic Atrophy" (1 trials), "Macular Degeneration" (1 trials), "Open Angle Glaucoma" (1 trials) and "Pterygium" (1 trials). Many other conditions were trialed in "Essendon Eye Clinic" in a lesser frequency.

Most popular intervention types in "Essendon Eye Clinic" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "0.1% AG-86893 Eye Drops" (1 trials), "0.3% AG-86893 Eye Drops" (1 trials), "IONIS-FB-LRx" (1 trials), "PA5108 Latanoprost FA SR Ocular Implant" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Essendon Eye Clinic" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Essendon Eye Clinic". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Essendon Eye Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Essendon Eye Clinic, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".